unknown
Stage
About
HERVolution Therapeutics develops novel immunotherapies that target human endogenous retroviruses (HERVs) to treat aging-related diseases including cancer, metabolic diseases, and neurodegenerative conditions.
Explore HERVolution Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.